IVGN: Invitrogen to Partner with Wave Biotech, LLC to Supply Media-Filled Disposable Bioreactor Bags

Invitrogen Corporation, a provider of essential life science technologies for disease research and drug discovery, and Wave Biotech, LLC, a research-based company that develops and manufactures innovative process equipment for the pharmaceutical and biotechnology industries, today announced they entered into a partnership to supply media-filled disposable bioreactors. Under the agreement, Invitrogen Corporation will offer its GIBCO(R) brand cell culture media products to Wave Bioreactor(R) users in filled Cellbag(R) brand disposable bioreactor bags.

Invitrogen will offer both standard and custom media products in the standard O-series Cellbag(R) format. Disposable bioreactors and Cellbags(R) are easily customized to suit specific cell culture process needs for research, development or cGMP manufacturing operations. Media-filled Wave O-series Cellbags(R) are available for ordering through Invitrogen's e-commerce and custom product channels.

"This partnership creates a tremendously convenient solution for bioreactor users and will substantially reduce customer prep time and the inherent contamination risks and raw materials tracking issues associated with self-filling of bioreactor vessels," said Nicolas Barthelemy, Senior Vice President of Invitrogen's Cell Culture Systems division. "Invitrogen has already received many customer requests for filled bags, and is pleased to offer this increased convenience to our customers."

"The Wave Bioreactor system is differentiated from the rest of the bioreactor market by its commitment to the highest standards of quality and end-user convenience," said Daniella Kranjac, Vice President, Sales and Marketing at Wave Biotech. "Invitrogen's commitment to making its quality products readily accessible to Wave Bioreactor customers, and its knowledge of the specialized needs of research and bioproduction customers, were key factors in our selection of Invitrogen as our partner for this endeavor."

About Invitrogen

Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company, which is celebrating 20 years of accelerating scientific discovery, provides essential life science technologies for disease research, drug discovery and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery, including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company globally employs approximately 4,800 scientists and other professionals and had revenues of more than $1.2 billion in 2005. For more information, visit www.invitrogen.com

About Wave Biotech, LLC

Wave Biotech is a research-based company that develops and manufactures innovative process equipment for the pharmaceutical and biotechnology industries. The Company's focus is on developing disposable bioprocessing equipment. Key products, such as the Wave Bioreactor(R), Wave Mixer(R), FlexMixer(R) and Sterile Tube Fuser, feature disposable contact materials that eliminate cleaning and validation, thereby reducing costs in operations ranging from cell culture, media preparation, and buffer dissolution and thawing process intermediates to patient-specific cell therapy in hospitals. These unique, patented devices can be installed and commissioned rapidly, thereby drastically reducing the time-to-market for biological products. For additional information, visit www.wavebiotech.com